Introduction
coronavirus disease 2019, ARDS
CORONAVIRUS DISEASE 2019, ACUTE RESPIRATORY DISTRESS SYNDROME, DISEASE, SAID, ARDS
Acute respiratory distress syndrome (ARDS) causes a significant reduction in long-term health quality; however, in most ARDS studies, the primary endpoint is patient mortality in the beginning.With improvements in intensive-care treatment, health-related quality of life (HRQoL) after survival of ARDS came into focus in the recent decade, and more than 200 instruments have been defined to assess HRQoL [To make long-term improvements for ARDS patients, rather than looking at the endpoint of a very differentiated disease pattern, the impact of single patient characteristics during ARDS therapy may help to interfere in advance, avoiding low HRQoL afterward. Therefore, we firstly strived to identify factors during intensive-care treatment of ARDS which significantly and independently influence functionality after  ICU  discharge, and can be used as outcome predictors in the future. Secondly, said factor or factors might not only serve as predictors, but could provide the chance to alter treatment and improve functionality after survival of ARDS.The recovery of patients and the quality of life after intensive care therapy for ARDS have even gained significant public interest during the coronavirus disease 2019 (COVID-19) pandemic due to the large number of patients requiring ARDS therapy.In this context, the question arises if ARDS based on COVID-19 is associated with a higher mortality or morbidity than ARDS of other origins, or if it’s “